PPARα is a ligand-activated transcription factor of clinical interest as a drug target in various metabolic disorders, which also contributes to the activity of endothelial nitric oxide synthase (eNOS) and regulates vascular tone [12, 25]. This evidence concerns the gene NOS3 and Other metabolic disease.